A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.
about
Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.Identification of genes and pathways in nasopharyngeal carcinoma by bioinformatics analysis.Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer.Identifying a Novel Biomarker of Clear Cell Renal Cell Carcinoma (ccRCC) Associated with Smoking by Co-Expression Network Analysis
P2860
A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A phase II study of Epirubicin ...... and TOP2A gene amplification.
@ast
A phase II study of Epirubicin ...... and TOP2A gene amplification.
@en
type
label
A phase II study of Epirubicin ...... and TOP2A gene amplification.
@ast
A phase II study of Epirubicin ...... and TOP2A gene amplification.
@en
prefLabel
A phase II study of Epirubicin ...... and TOP2A gene amplification.
@ast
A phase II study of Epirubicin ...... and TOP2A gene amplification.
@en
P2093
P2860
P50
P1433
P1476
A phase II study of Epirubicin ...... r and TOP2A gene amplification
@en
P2093
Diana R Andersen
Jan Stenvang
Niels Frank Jensen
Nils Brünner
Signe L Nielsen
Sune B Nygård
Sönke Detlefsen
P2860
P2888
P356
10.1186/S12885-016-2124-5
P407
P577
2015-01-01T00:00:00Z
P5875
P6179
1043542237